FDA Approves FoundationOne Liquid CDx Liquid Biopsy Test
Foundation Medicine’s FoundationOne Liquid CDx is a pan-tumor liquid biopsy test for patients with solid tumors.
Read MorePosted by Melanie Hamilton-Basich | Aug 29, 2020 | Cancer, Molecular Diagnostics |
Foundation Medicine’s FoundationOne Liquid CDx is a pan-tumor liquid biopsy test for patients with solid tumors.
Read MorePosted by Laurie Bonner | Aug 28, 2020 | Company News, Covid 19 |
The $760 million agreement is for 150 million rapid coronavirus tests called BinaxNOW made by Abbott Laboratories.
Read MorePosted by Laurie Bonner | Aug 27, 2020 | Information Technology, Sepsis |
Device manufacturers that unravel technical and regulatory issues will lead the fight.
Read MorePosted by Laurie Bonner | Aug 27, 2020 | Point-of-Care |
Moving diagnostic technology to the clinical setting is key to the fight against antibiotic resistance.
Read MorePosted by Melanie Hamilton-Basich | Aug 27, 2020 | Covid 19, Information Technology |
This pooled covid-19 testing builds on existing infrastructure being used by a growing network of labs currently testing for covid-19 on an individual basis.
Read More